1. Home
  2. BLMN vs PHAR Comparison

BLMN vs PHAR Comparison

Compare BLMN & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLMN
  • PHAR
  • Stock Information
  • Founded
  • BLMN 1988
  • PHAR 1988
  • Country
  • BLMN United States
  • PHAR Netherlands
  • Employees
  • BLMN N/A
  • PHAR N/A
  • Industry
  • BLMN Restaurants
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLMN Consumer Discretionary
  • PHAR Health Care
  • Exchange
  • BLMN Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • BLMN 714.5M
  • PHAR 718.1M
  • IPO Year
  • BLMN 2012
  • PHAR N/A
  • Fundamental
  • Price
  • BLMN $7.63
  • PHAR $10.60
  • Analyst Decision
  • BLMN Hold
  • PHAR Strong Buy
  • Analyst Count
  • BLMN 11
  • PHAR 3
  • Target Price
  • BLMN $13.75
  • PHAR $30.00
  • AVG Volume (30 Days)
  • BLMN 2.9M
  • PHAR 3.1K
  • Earning Date
  • BLMN 05-07-2025
  • PHAR 05-08-2025
  • Dividend Yield
  • BLMN 7.86%
  • PHAR N/A
  • EPS Growth
  • BLMN N/A
  • PHAR N/A
  • EPS
  • BLMN N/A
  • PHAR N/A
  • Revenue
  • BLMN $3,930,996,000.00
  • PHAR $320,708,000.00
  • Revenue This Year
  • BLMN $1.28
  • PHAR $13.31
  • Revenue Next Year
  • BLMN $1.67
  • PHAR $7.68
  • P/E Ratio
  • BLMN $8.44
  • PHAR N/A
  • Revenue Growth
  • BLMN N/A
  • PHAR 24.13
  • 52 Week Low
  • BLMN $6.09
  • PHAR $6.65
  • 52 Week High
  • BLMN $22.34
  • PHAR $11.07
  • Technical
  • Relative Strength Index (RSI)
  • BLMN 45.27
  • PHAR 62.25
  • Support Level
  • BLMN $7.62
  • PHAR $10.02
  • Resistance Level
  • BLMN $8.03
  • PHAR $10.89
  • Average True Range (ATR)
  • BLMN 0.43
  • PHAR 0.27
  • MACD
  • BLMN -0.07
  • PHAR 0.07
  • Stochastic Oscillator
  • BLMN 14.37
  • PHAR 86.82

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: